Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care
BOSTON, May 29, 2025 /PRNewswire/ -- Outcomes4Me Inc., the developer of the leading direct-to-patient, AI-driven platform transforming the cancer care experience, today announced the close of a $21M funding round.
"AI will reshape cancer care, and this investment accelerates our ability to deliver personalized treatments and improved outcomes to patients at scale," said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. "With more than 280,000 cancer patients using our AI-enabled platform, we're not just offering people diagnosed with cancer a tool, we're empowering them with intelligent, real-time insights that guide them through every step of their care. This funding will help us further enhance our platform, expand our reach, and drive meaningful revenue growth."
With this round, Outcomes4Me welcomes new investor London-based Salica Investments, with participation from all existing investors: Labcorp Venture Fund, Forecast Labs, Northpond Ventures, Sierra Ventures, Asset Management Ventures, IRA Capital, and Merstal LTD, bringing Outcomes4Me's total capital raised to date to $38M.
AI at the Core of Cancer Care
The future of cancer care is digital, data-driven, and deeply personalized. Outcomes4Me's AI-driven platform integrates real-time clinical guidelines, genomic insights, medication and symptom tracking, clinical trial matching, and patient peer communities into a single, easy-to-use interface for patients with cancer. By combining cutting-edge AI with deep oncology expertise and generating new multimodal patient-level data enriched at the drug level, Outcomes4Me is uniquely positioned to accelerate the pace of innovation in cancer care, driving both improved patient outcomes and sustainable revenue growth.
"Outcomes4Me is an AI-driven pioneer in the oncology space, scaling rapidly in a market that demands smarter, personalized healthcare solutions," said Amy Summy, Executive Vice President, Chief Marketing Officer and Consumer Lead for Labcorp. "We are excited to support their digital platform as part of our deep commitment to help advance oncology care and improve patient outcomes."
Track Record of Success
Outcomes4Me's business is focused on accelerating innovation and improving outcomes by partnering with life sciences companies to help them reach the right patient at the right time with the right action. Since its commercial launch in 2022, the company has been on an incredible revenue growth trajectory, reflecting the increasing demand for smarter, more personalized cancer-care solutions. Notably, seven out of the top 10 global cancer pharmaceutical companies are already among Outcomes4Me's valued customers, further demonstrating its market leadership.
Outcomes4Me's innovation has been widely recognized, generating more than 15 industry awards in the past three years, including being named a Fast Company World Changing Idea. Most recently, the company ranked #12 on the Inc. Regionals Northeast 2025 list, jumping from #70 the previous year, and the 2025 EY Entrepreneur of the Year program for the New England region named Outcomes4Me Founder and CEO Dr. Maya R. Said a finalist. An independent peer-reviewed study published in Current Oncology identified Outcomes4Me as the highest quality application among over 3,000 applications for adults with cancer worldwide.
Revenue Growth and Global Expansion: A Key Focus for the Future
As part of its trajectory to become the leading global digital health solution for cancer care, Outcomes4Me is making strategic moves toward expanding internationally with a goal to make a profound impact on global cancer care standards. With this new funding, Outcomes4Me will:
Accelerate its market penetration across a broader range of cancer types, geographies, and global markets
Leverage its proprietary datasets and expand its AI capabilities to drive even more precise, real-time personalized treatment recommendations
Strengthen and scale its collaborations with top-tier health systems and life sciences companies globally
Scale its revenue streams through new partnerships, international expansion, and innovative business models
Drive outcomes-based evidence generation and real-world data insights for improved treatment and care
About Outcomes4Me
Outcomes4Me is the first and only end-to-end, AI-driven patient empowerment platform that helps patients with cancer take a proactive approach to their care from diagnosis throughout every stage of life and care. Its direct-to-patient platform integrates clinical guidelines, genomics, trial matching, and symptom tracking to help patients navigate through a cancer diagnosis with confidence and clarity. Through its patented technology, Outcomes4Me is redefining cancer care by delivering smarter, AI-powered solutions that put patients in control of their treatment decisions. What sets Outcomes4Me apart is its ability to generate unique, at-scale proprietary datasets that enable more precise and actionable insights for better patient outcomes. Based in Boston, Massachusetts, Outcomes4Me is a woman-led company of seasoned healthcare, oncology, pharmaceutical, consumer and technology veterans. For more information, visit www.outcomes4me.com.
View original content:https://www.prnewswire.com/news-releases/outcomes4me-secures-21m-in-funding-to-accelerate-ai-driven-innovation-and-drive-global-expansion-to-transform-cancer-care-302468806.html
SOURCE Outcomes4Me Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
Faraday Future Announces Global Music Legend and Best-Selling Female Artist Mariah Carey will Become the Next FF 91 2.0 Owner
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ('Faraday Future', 'FF' or 'Company'), a California-based global shared intelligent electric mobility ecosystem company, today announced that award-winning, best-selling female artist of all time and global top music legend Mariah Carey will become the next FF 91 2.0 Futurist Alliance owner. Mariah Carey will take delivery of her FF 91 2.0 soon and just released her new official music video Type Dangerous featuring the FF 91 and FFZERO1 concept car; stay tuned for more updates. The synergy between FF's spire (Ultimate AI Luxury) brand positioning and iconic users continues to grow. This marks the formation of a high-recognition, high-loyalty brand influence loop, and signals that FF has officially entered a new phase of global cultural co-creation. Mariah Carey's addition to the FF celebrity owner family — which already includes numerous high-profile figures — marks yet another superstar and cultural icon member. Moreover, this reinforces FF's growing influence of celebrities, athletes and music icons which reinforce FF's brand power and the extreme product power of the FF 91 2.0 EV. It's not just a luxury vehicle; it's a symbol of futurism, cutting-edge technology, and AI innovation. 'I want to congratulate Mariah Carey on her newly released single and music video release and for becoming the newest owner of the FF 91 2.0,' said YT Jia, FF founder and Global Co-CEO of Faraday Future. 'The FF 91 2.0 represents the pinnacle of Ultimate AI TechLuxury. Having an iconic owner like Mariah Carey reaffirms FF's position in the global EV landscape.' ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit ABOUT MARIAH CAREY Mariah Carey is the best-selling female artist of all time with more than 200 million albums sold to date and 19 Billboard Hot 100 #1 singles (18 self-penned), more than any solo artist in history. Carey - an inductee to the Songwriters Hall of Fame - is a singer, songwriter & producer recognized with multiple Grammy Awards, numerous American Music Awards, three Guinness World Record titles, Billboard's 'Artist of the Decade' Award, Billboard's 'Icon Award,' the World Music Award for 'World's Best Selling Female Artist of the Millennium,' the Ivor Novello Award for 'PRS for Music Special International Award,' and BMI's 'Icon Award' for her outstanding achievements in songwriting, to name a few—with her distinct five-octave vocal range, prolific songwriting, and producing talent, Carey is truly the template of the modern pop performance. Carey's ongoing impact has transcended the music industry to leave an indelible imprint upon the world at large. In 2009, Carey was recognized with the Breakthrough Performance Award at the Palm Spring International Film Festival for her critically acclaimed role in Lee Daniels' 'Precious.' Carey went on to appear in Daniels' ensemble piece 'The Butler' (2013). A Congressional Award recipient, Carey has generously donated her time and energy to a range of philanthropic causes near to her heart including Save the Music, the Make-A-Wish Foundation, World Hunger Relief, and the Elton John AIDS Foundation, among many others. A tremendous supporter of children's charities, both domestic and international, Carey founded Camp Mariah in partnership with the Fresh Air Fund, a retreat for inner city children to explore career development. FORWARD LOOKING STATEMENTS This press release includes 'forward looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'estimates,' 'projected,' 'expects,' 'anticipates,' 'forecasts,' 'plans,' 'intends,' 'believes,' 'seeks,' 'may,' 'will,' 'should,' 'future,' 'propose' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding the future FF 91 2.0 ownership and collaboration with Mariah Carey, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, among others, that Mariah Carey may choose to not accept the FF 91. You should carefully consider the foregoing factors and the other risks and uncertainties described in the 'Risk Factors' section of the Company's Form 10-K filed with the SEC on March 31, 2025, and other documents filed by the Company from time to time with the SEC.
Bloomberg
41 minutes ago
- Bloomberg
London Home Prices Cut to Lure Tax-Hit Buyers, Rightmove Says
London home sellers slashed almost £7,000 ($9,481.5) off their asking prices in June to attract buyers facing higher taxes and greater choice, according to real estate agents. The average price sought fell 0.9% to £695,414, according to a report by property website Rightmove published Monday. Sellers in the UK capital and other pricey regions are offering discounts to offset the impact of April's increase in transaction costs.
Associated Press
an hour ago
- Associated Press
Both ISS and Glass Lewis Recommend Shareholders Vote AGAINST Keisei President Toshiya Kobayashi, Endorsing Palliser's Call for Governance Reform
LONDON--(BUSINESS WIRE)--Jun 15, 2025-- Palliser Capital ('Palliser'), one of the largest shareholders of Keisei Electric Railway Co., Ltd. (9009 JT) ('Keisei' or the 'Company') with a shareholding over 4.5%, today welcomed the recommendations by ISS and Glass Lewis that shareholders vote AGAINST the re-election of current President Toshiya Kobayashi and other directors at the Company's upcoming Annual General Meeting on June 27, 2025. Both ISS and Glass Lewis echoed serious concerns with Keisei's governance practices in their research reports, citing: ISS concluded that 'Palliser has made a compelling case that a governance overhaul at Keisei is necessary to restore trust in management', while Glass Lewis concluded that withholding support for Toshiya Kobayashi would serve as a 'measured signal to prompt meaningful improvements in Keisei's governance and transparency practices.' James Smith, Founder and Chief Investment Officer of Palliser, commented: 'ISS and Glass Lewis' recommendations validate our concerns and underscore the importance of holding leadership accountable. We urge shareholders to vote against current President Toshiya Kobayashi, outside directors Shotaro Tochigi, Misao Kikuchi, and Takako Amitani, and proposed new inside directors Kunihiko Yoshikawa and Takeshi Hashimoto.' Full details relating to Palliser's ongoing engagement are available About Palliser Capital Palliser Capital is a global multi-strategy fund. Our value-oriented investment philosophy is applied to a broad range of opportunities across the capital structure with a focus on situations where positive change and value enhancement can be achieved through thoughtful, constructive and long-term engagement with companies and across a range of different stakeholder groups. Palliser Capital is one of the largest Keisei shareholders with a stake in excess of 4.5%. View source version on CONTACT: Media Prosek Partners Brian Schaffer / Kiki Tarkhan / Forrest Gitlin [email protected] KEYWORD: UNITED KINGDOM EUROPE INDUSTRY KEYWORD: RAIL PROFESSIONAL SERVICES TRANSPORT FINANCE SOURCE: Palliser Capital Copyright Business Wire 2025. PUB: 06/15/2025 07:00 PM/DISC: 06/15/2025 07:04 PM
